Breaking
Live coverage: developing stories updated in real timeSubscribe for verified alerts as news breaksLive coverage: developing stories updated in real timeSubscribe for verified alerts as news breaksLive coverage: developing stories updated in real timeSubscribe for verified alerts as news breaksLive coverage: developing stories updated in real timeSubscribe for verified alerts as news breaksLive coverage: developing stories updated in real timeSubscribe for verified alerts as news breaksLive coverage: developing stories updated in real timeSubscribe for verified alerts as news breaks
HomeHealth

Vaccine trial reports strong results in late-stage study

Efficacy topped 90% across all age groups.

ER
By Elena Rossi
Newsmonger
Published July 5, 2026Updated July 5, 2026 1 min read 14.1K views
Text M
Vaccine trial reports strong results in late-stage study
Efficacy topped 90% across all age groups.

Regulators will now review the full dataset.

Share this story
ER
Written by
Elena Rossi

Health and science correspondent.

More stories by Elena
Comments

Join the conversation

Comments on this article are currently closed. Administrators can enable discussion from the newsroom settings.